Bacterial Infections clinical trials at University of California Health

1 research study open to eligible people

Showing trials for

  • VABOMERE in Pediatric Subjects With Bacterial Infections

    open to eligible people ages up to 17 years

    A single dose infusion of Vabomere (meropenem-vaborbactam) is being tested for dose-finding, pharmacokinetics, safety, and tolerability in pediatric subjects from birth to less than 18 years of age with serious bacterial infections

    at UCLA

Our lead scientists for Bacterial Infections research studies include .

Last updated: